UNSPSC 51281683: Porfiromycin

This classification denotes a mitomycin antibiotic with the molecular formula C16H20N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H1WK901OA6, chemically known as 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-1,5-dimethylazirino(2,3:3,4)pyrrolo(1,2-a)indole-4,7-dione carbamate (ester) but more generally known as porfiromycin, which bears US NIH Compound Identifier 13116. European Medicines Agency schedules Porfiromycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09980MIG.

The term PORFIROMYCIN is an International Non-Proprietary Name. PORFIROMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C12N(CC3N(C13)C)C1=C(C2COC(=O)N)C(=O)C(=C(C1=O)C)N)C.

UNSPSC 51281683 Porfiromycin is a Commodity code that, based on recent state and local solicitation activity, does not map clearly to the pharmaceutical procurement work currently being conducted under it. The recent opportunities tagged to this code include naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas HHS Commission), medical and first aid supplies for fire rescue operations (City of Tampa), and generic multi-source pharmaceuticals and OTC products through a cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance). These solicitations span naloxone procurement, emergency medical supplies, therapeutic pharmacy initiatives, and broad-based pharmaceutical contracting—none of which align to porfiromycin specifically, a specialized pharmaceutical with a narrow clinical indication. The issuing bodies include county health departments, state health agencies, municipal fire departments, and state procurement offices executing cooperative purchasing agreements that serve multi-state membership.

Geographic activity appears concentrated in Florida, Texas, Minnesota, and Oregon, with the Minnesota cooperative purchasing vehicle serving participating state and local members across multiple jurisdictions. Representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023), the City of Tampa's invitation to bid for medical and first aid supplies for its Fire Department Rescue Division with an estimated contract value of $700,000 and responses due March 13, 2026, Texas HHS Commission's RFI on direct-to-manufacturer prescription programs (due April 3, 2026), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products with responses due March 26, 2026. The code shows recent activity but limited relevance to porfiromycin procurement; bidders should verify actual commodity scope with issuing bodies before pursuing opportunities under this code.